The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...

The Centers for Disease Control and Prevention have issued a new recommendation to protect babies against RSV. According to the updated guidelines, infants under the age of 8 months should receive a ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

Influenza and other respiratory viruses are starting to circulate but so far remain lower than this time last year, according to the Centers for Disease Control and Prevention. As of Oct. 7, CDC's ...